BOLIGNANO, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 1.887
EU - Europa 1.524
AS - Asia 459
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.873
Nazione #
US - Stati Uniti d'America 1.883
SE - Svezia 532
IE - Irlanda 489
CN - Cina 262
SG - Singapore 170
DE - Germania 130
UA - Ucraina 118
FI - Finlandia 87
IT - Italia 73
GB - Regno Unito 51
IN - India 24
FR - Francia 18
CZ - Repubblica Ceca 11
BE - Belgio 10
CA - Canada 4
RU - Federazione Russa 3
IR - Iran 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
CH - Svizzera 1
EC - Ecuador 1
IQ - Iraq 1
RO - Romania 1
Totale 3.873
Città #
Chandler 499
Dublin 489
Jacksonville 282
Nyköping 251
Singapore 134
Beijing 119
Ashburn 95
Dearborn 90
Princeton 73
Cambridge 69
Medford 64
Des Moines 56
Ann Arbor 50
Boardman 50
New York 35
Bremen 25
Lancaster 22
Helsinki 21
San Mateo 20
Woodbridge 19
Jinan 18
Munich 17
Wilmington 16
Pune 13
Nanjing 12
Seattle 12
Los Angeles 11
Brussels 10
Shenyang 10
Hebei 9
Ningbo 9
Augusta 8
Brno 8
Haikou 8
Houston 8
Falls Church 7
Hyderabad 7
Nanchang 7
Tappahannock 7
Leawood 6
Jiaxing 5
Norwalk 5
Tianjin 5
Washington 5
Zhengzhou 5
Guangzhou 4
Hangzhou 4
Santa Clara 4
Clearwater 3
Foggia 3
Lanzhou 3
Lentini 3
Licata 3
Olomouc 3
Rome 3
Taiyuan 3
Taizhou 3
Bologna 2
Caltagirone 2
Capurso 2
Catania 2
Changsha 2
Fuzhou 2
Hefei 2
Messina 2
Mira 2
Montréal 2
Naples 2
Palermo 2
Porretta Terme 2
Shanghai 2
Toronto 2
Trento 2
Acquaviva Picena 1
Basel 1
Bergamo 1
Borgomasino 1
Brasov 1
Büdelsdorf 1
Cagliari 1
Chengdu 1
Clifton 1
Council Bluffs 1
Croydon 1
Cuenca 1
Cupertino 1
Eschweiler 1
Fiumefreddo Di Sicilia 1
Florence 1
Fushan 1
Harbin 1
Jeffries 1
Kaifeng 1
Kunming 1
La Paz 1
Las Vegas 1
Milan 1
Mumbai 1
Nantong 1
Napoli 1
Totale 2.789
Nome #
Both IL-1β and TNF-α Regulate NGALExpression in Polymorphonuclear Granulocytes ofChronic Hemodialysis Patients 89
Neutrophilgelatinase-associatedlipocalin(NGAL); un biomarker oltre i confini della nefrologia 84
Dialysis and the Elderly: An Underestimated Problem. 81
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 75
The erythropoietin and regenerative medicine: a lesson from fish 72
Cold pressor test stimulates the mobilization of endothelial progenitor cells in hypertensive and uremic patients 70
Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment. 70
A new therapy for kidney injury: regeneration. 70
Caffeine and the kidney: What evidence right now? 69
Effect of immunoglobulin treatment on endothelial progenitor cells in systemic lupus erythematosus 68
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R). 67
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 65
Neurobiological model and quality of life in discovering personality of the uremic patient. 64
Circulating endothelial progenitor cell mobilization in centenarians: a powerful source for extended renal life. 64
Acute cardiovascular complications of hemodialysis. 63
Malnutrition in the elderly patient on dialysis. 62
A brief "update" on renal effects of caffeine 62
Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? 61
Down with the erythropoietin. Long live the erythropoietin! 61
Aquaporin-2 (AQP2) urinary excretion and assumption of water with different mineral content in healthy subjects 61
Circulating progenitor cells after cold pressor test in hypertensive and uremic patients 60
Renal complications in oncohematologic patients. 60
Arrhythmias and hemodialysis: role of potassium and new diagnostic tools. 60
Therapy with vasopressin receptor antagonists: the aquaretics 60
From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine 59
Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. 58
[Erythropoietin: pleiotropic actions]. 58
Aquaretic agents: What's beyond the treatment of hyponatremia? 57
Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis 57
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization. 57
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease 56
Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients 56
Effects of haemodialysis on circulating endothelial progenitor cell count 56
Aquaretic-induced apoptosis: a cure or a curse? 55
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage 55
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and progression of chronic kidney disease. 55
Xanthine oxidase inhibitors for improving renal function in chronic kidney disease patients: An updated systematic review and meta-analysis 55
Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function 54
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 54
Experimental therapies in renal replacement: The effect of two different potassium acetate-free biofiltration protocols on striated muscle fibers 54
Erythropoietin and its lost receptor [8] 53
Levels of neutrophil gelatinase-associated lipocalin in 2 patients with crush syndrome after a mudslide. 52
Pregnancy in uremic patients: An eventful journey 51
A case-by-case protocol of membranous nephropathy treatment with endovenous infusion of high doses of human immunoglobulins 49
Pulmonary hypertension and erythropoietin. 48
Erythropoietin and its lost receptor. 48
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. 47
Endothelial progenitor cells: pathogenetic role and therapeutic perspectives 47
Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade. 47
Il Cold Pressor Test stimola la mobilizzazione di cellule staminali ad indirizzo endoteliale nei soggetti ipertesi ed uremici 47
Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein. 47
Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. 46
Erythropoietin and cancer: an old risk. 46
RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus 46
Parathyroid hormone and mobilization of circulating bone marrow-derived cells in uremic patients. 45
Regenerative medicine: does Erythropoietin have a role? 45
Obestatin: a new element for mineral metabolism and inflammation in patients on hemodialysis. 44
Modifications in relaxin's serum levels during acetate-free biofiltration (AFB): only a new biomarker? 42
From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. 41
NGAL is a precocious marker of therapeutic response. 40
null 39
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 39
Genomic damage in endothelial progenitor cells from uremic patients. 38
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 38
Endothelial progenitor cells at the interface of chronic kidney disease: from biology to therapeutic advancement 37
Osteoprotegerin and carotid atherosclerosis in dialysis patients: An imaging (ECO-Doppler) and genic expression study 36
NGAL: a new missing link between inflammation and uremic anemia? 35
Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients. 34
Neutrophil gelatinase-associated lipocalin in the intensive care unit: time to look beyond a single, threshold-based measurement? 32
Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: An observational retrospective cohort study 32
null 30
Preeclampsia and cardiovascular risk: general characteristics, counseling and follow-up. 23
Renal Concerns in the Treatment of Chronic Hepatitis B with Tenofovir 19
null 16
Neutrophil gelatinase-associated lipocalin levels in patients with crohn disease undergoing treatment with infliximab. 16
Totale 3.909
Categoria #
all - tutte 17.357
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.357


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020405 0 0 0 0 8 89 78 54 10 86 76 4
2020/2021408 63 4 69 33 16 60 6 24 7 39 57 30
2021/2022544 2 73 5 19 32 4 26 17 3 120 76 167
2022/20231.563 134 169 75 144 124 152 9 94 609 7 31 15
2023/2024326 31 50 14 32 27 98 2 21 0 14 5 32
2024/2025233 24 14 53 99 43 0 0 0 0 0 0 0
Totale 3.909